Grasp the latest information from Olin and understand the new trends in the industry.
Recently, the Recombinant Five-antigen Staphylococcus Aureus Vaccine (rFSAV), a Class 1.1 New Drug co-developed by Chengdu Olymvax Biopharmaceuticals Inc.
Feb 18th 2025, Olymvax and Griffith University of Australia held a signing ceremony in Chengdu for their collaboration on the GAS project and contract manufacturing of GAS vaccine.
On June 8, Chengdu Olymvax Biopharmaceuticals Inc. was successfully listed on the Science and Technology Venture Board of Shanghai Stock Exchange. OLYMVAX (688319.SH) issued 40,530,000 shares at a price of RMB 9.88 per share, raising a total of RMB 400,436,400, with a total share capital of 405,265,000 shares after the issuance.
The Spring Festival of 2021 was destined to be an extraordinary Spring Festival. In the context of the resurgence of COVID-19, in order to stabilize the development of all enterprises, promote them to get off to a good start in 2021, and let the employees of all enterprises spend the New Year in Chengdu with peace of mind, Vice Director Zeng Ke and his delegation, along with five companies in the biological industry and the Association of Experts in Chengdu High Tech Bio-industry, held a special
He once led Sichuan Shuyang to become a leading enterprise in the blood product industry, led Zhongyuan Ruide from loss to profit in just three years to realize consecutive sales growth, and also revitalized Guiyang Qianfeng Bio-Products, then merged it into Taibang Biologic Group, and successfully entered the overseas capital market...In the more than 40 years of work, Fan Shaowen, a maker in Chengdu High-tech Zone, has repeatedly performed the “Midas Touch” to make many biological products ent
On March 17, 2020, the Cash-in of the First Batch of Project Policies and the Symposium of Biological Enterprises under “Measures to Strengthen Technological Breakthroughs and Material Support for COVID-19 Prevention and Control in Chengdu High-tech Zone” was held in Chengdu High-tech Zone to support 18 enterprises and 2 provincial medical institutions that deeply participated in epidemic prevention and control and made practical contributions.